Vaginal Clindamycin Cream Plus Vaginal Probiotic for Bacterial Vaginosis

Zagazig University

Status and phase: Unknown; Phase 2

Conditions: Bacterial Vaginosis Treatment

Treatments: Drug: Vaginal Probiotic; Drug: Vaginal Clindamycin Cream

Study type: Interventional

Funder types: Other

Identifiers

NCT03234517

zuh- 8

Details and patient eligibility

About

Vaginal Clindamycin Cream Plus Vaginal probiotic for treatment of Bacterial Vaginosis

Full description

Vaginal Clindamycin Cream was used initially for treatment of Bacterial Vaginosis followed by Vaginal probiotic either in cnotinous or interrupted manner, then assessment of the results of treatment at different time intervals was done.

Enrollment: 200 estimated patients

Sex: Female

Ages: 18 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• more than 18 years
• has recurrent Bacterial Vaginosis

Exclusion criteria

• pregnancy
• use of other antmicrobial
• not provide informed consent

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

200 participants in 2 patient groups

Vaginal Clindamycin Cream Plus continuous Vaginal Probiotic

Experimental group

Description:

Vaginal Clindamycin Cream followed by continuous Vaginal Probiotic use for 60 days

Treatment:

Drug: Vaginal Clindamycin Cream

Drug: Vaginal Probiotic

Vaginal Clindamycin Cream Plus interrupted Vaginal Probiotic

Active Comparator group

Description:

Vaginal Clindamycin Cream followed by interrupted Vaginal Probiotic use

Treatment:

Drug: Vaginal Clindamycin Cream

Drug: Vaginal Probiotic